Presented by: Omar Aziz, PhD, Charles River

About Episode 3

In episode 3, Omar shares the main reasons why drug programs fail. He outlines a successful program- one in which quality, speed and cost are monitored closely and one that tracks how the molecule/compound will translate from start to finish.

About Omar Aziz

Omar is the Director of Biology at Charles River's Early Discovery unit in Cambridge, UK which partners with companies to develop new compounds. He has a PhD from the University of Newcastle-upon-Tyne and completed his postdoctoral studies at the NIEHS, Research Triangle Park in North Carolina.

Complete the form to the right for access to episode 3 of the Charles River Innovator's Series.

Also Available from the Charles River Innovator’s Series...

Ready to collaborate?

Connect with an Advisor